Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
US7273852B2 · kind B2 · utility
33Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2003 |
| Grant date | Sep 25, 2007 |
| Priority date | — |
| Expiry date | Jun 13, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to compounds of formula (I)wherein X is O or NH; R′ is a hydrocarbon chain; R3 and R4 are hydrogen, OH or a monosaccharide; R5 is hydrogen or a monosaccharide; Q′ is optionally present and may be a C1-10 hydrocarbon; X′ is optionally present and may be O, S or NR8; and Q3 may be a hydrocarbon or hydrogen. The invention is also directed to the use of the compounds for treating cancer, infectious diseases and autoimmune diseases. The invention is also directed to syntheses of the compounds of formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.